EMBRYONIC & ADULT STEM CELLS

To know more: https://bit.ly/2PhhIOg
To enroll:https://bit.ly/2L0waXN

World Congress on Tissue Engineering and Regenerative Medicine
March 14-15,2019
London, UK

Donor age does not likely to influence the capability of stem cells from adult body tissues, latest studies report. The analysis of research on induced pluripotent stem cells proves that not only are typical signs of aging reversed in iPSCs, but cells derived from both older and younger donors show the same potential to differentiate into mature cells. This portrays iPSCs as a viable alternative to embryonic stem cells in regenerative medicine.

Unlike most cells in the body, stem cells develop into different cell types. Their discovery opened the possibility of culturing specific cells to treat damaged tissues, organs, degenerative diseases and genetic diseases.

Stem cells can be derived from two sources: embryos and adult tissues. It was believed that embryonic stem cells are the indispensable source, as these "young" cells have not undergone the same level of cell damage as older cells.

However, embryonic stem cells also have limitations such as ethical concerns, immunological rejection of transplanted tissue derived from ESCs, and limited availability of the donor.

Therefore, it is a unmatchable medicine that has been discovered and there is yet to find out more from the hidden treasure “Stem cells”.

World Congress on Tissue Engineering and Regenerative Medicine
March 14-15, 2019
London, UK
To know more: https://bit.ly/2wRDXmt

To be a part: https://bit.ly/2L0waXN


Stem Cells &Parkinson's Disease

Stem cells are capable of self-differentiating into different cell types of the body. The classic examples are the embryonic stem cells. These cells can proliferate into all the major cell types of the body. Stem cells have also been isolated from bone marrow, muscle, heart, gut, and even the brain. Special stem cells in the bone marrow form various types of blood cells.

Stem cell research vitally impacts the development of disease-modifying treatments for Parkinson's disease. Cell models of Parkinson's disease obtained from stem cells could help researchers screen drugs more productively than in animal models, and study the underlying biological mechanisms associated with Parkinson's disease.

In addition to ES cells, induced pluripotent stem (iPS) cells, discovered in 2007, represent an important development in stem cell research to treat diseases like Parkinson's disease. Essentially, iPS cells are "man-made" stem cells. These cells have potential both for cell replacement treatment and as disease models that scientists could use.

A potentially exciting use for iPS cells is the development of cell models of Parkinson's disease. Researchers could profoundly make use of these cell models to examine genetic and environmental factors insanely suspected in Parkinson's disease.

World Congress on Tissue Engineering and Regenerative Medicine
London, UK
March 14-15, 2019
To know more: https://bit.ly/2L0gq72


Stem cells in treating Heart Diseases

Stem cells are a group of unspecialized cells in the body which is capable of self-differentiating. These Stem cells are pluripotent. They are capable of developing into any desired tissue.

Stem cells are usually obtained from Umbilical cord blood as soon as the child is born. But stem cells can also be obtained from the blood and adipose tissue as well.

Advancements in science also partially prove the presence of stem cells in all the tissues. The stem cells in other tissues are specific cells among the other specialized cells which are capable of limited cell division. Hence it is suspected to help in the regeneration of tissues.

Recent studies conducted in implementing the stem cells in cardiac treatment showed reasonably a good result. It was done primely for cardiac diseases because globally the percentage of people affected with cardiac diseases had notably increased.

Researches proved that when stem cells were implemented in treating cardiac diseases, they regenerated the heart tissue and hence there was an increase in the efficiency of pumping in the cardiac muscle.

Also, another study in Japan proved the efficiency of stem cells in autologous somatic tissues by placing a patch of skin on the damaged part of the heart taken from the thighs of the same person. This also showed considerable positive result in cardiac treatment.

Thus rather than placing a Pacemaker which helps in the contraction of heart muscles or an

Implantable cardioverter defibrillator, which sets rights the rhythm of the heart, Stemcells are found to be an ideal one and it is also stated that there is no profound immune response noticed. Thus Stem cell has emerged as a unique field but connected to every single organ of the body.

World Congress on
Tissue Engineering and Regenerative Medicine
March 14-15,2019
London, United Kingdom

To know more visit:https://bit.ly/2L0gq72

Current Researches on Stem Cells – An overview

Stem cells are cells that can differentiate into various types of cells and divide to produce its own type as well.Stem cells act as repair system for the body, restoring adult tissues. Stem cells are obtained from the Umbilical cord blood soon after the birth of a baby. It is also acquired from the bone marrow, blood and adipose tissue in adults.

Adult stem cells are extensively used in various therapies.

Current studies are based on how stem cells may be used to prevent or cure diseases such as Parkinson's disease, type 1 diabetes, heart disease, spinal cord injury, muscular dystrophy, Stem cells could be used to replace or repair damaged tissue.

Recently, Stem cell therapy has been implemented in testing for erectile restoration in animal models. Stem Cells derived from multiple tissues have varied potential, and may function via local engraftment or paracrine signaling. Bone marrow-derived stem cells and adipose-derived stem cells have been used in this research and has yielded a promising effect.

The most important and interesting factor why scientists and researchers are much interested in stem cell might be  because in nearing future healthy heart cells could be developed in a laboratory may one day be transplanted into patients with heart disease, refilling the heart with healthy tissue.

Likewise, patients suffering from type I diabetes might be provided with pancreatic cells to replace the insulin-producing cells that have been destroyed by body’s own immune system. This is the only current therapy in research process whereas the present treatment is only pancreatic transplant which is actually a tedious one and is rarely successful.